노스캐롤라이나의 중증근무력증 임상 시험
중증근무력증 관련 연구 14개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.
노스캐롤라이나의 도시
공식 연구 텍스트(영어)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Velocity Clinical Research, Inc., Raleigh
- Atrium Health Wake Forest Baptist, Winston-Salem
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Fayetteville
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07647510ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- University of North Caroline at Chapel Hill-170 Manning Dr, Chapel Hill
- Duke Early Phase Clinical Research Unit - PPDS, Durham
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07284420ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- University of North Carolina at Chapel Hill-170 Manning Dr., Chapel Hill
- Duke Early Phase Clinical Research Unit - PPDS, Durham
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07294170A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, New Bern
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- UNC Hospitals - PARENT, Chapel Hill
- Atrium Health Wake Forest Baptist, Winston-Salem
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT06463587Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- The University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06414954Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1020, Chapel Hill
- Site Number - 1013, Durham
- Site Number - 1044, Raleigh
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Duke University School of Medicine, Durham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of North Carolina Hospitals - Neurology Clinic, Chapel Hill
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 6. 18. 업데이트됨 · NCT06456580A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Raleigh
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT07221838Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중2/3상
2세 ~ 18세 · 모든 성별 · 2026. 2. 18. 업데이트됨 · NCT04833894Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Chapel Hill
- Clinical Trial Site, Charlotte
- Clinical Trial Site, Durham
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 2. 18. 업데이트됨 · NCT04202341The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- Duke University, Durham
피험자 모집 중건강한 지원자 환영
18세 이상 · 모든 성별 · 2025. 4. 11. 업데이트됨 · NCT05564936ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.